Laboratory Findings in Chronic Hepatitis B Without Coma
Chronic hepatitis B without coma is definitively diagnosed by HBsAg positivity for >6 months, with additional positive markers including anti-HBc (IgG), detectable HBV DNA, and either HBeAg (in active replication) or anti-HBe (in lower replication states), along with elevated or normal ALT/AST depending on disease phase. 1
Core Serologic Markers Always Positive
- HBsAg (Hepatitis B Surface Antigen): This is the hallmark marker that must be positive for >6 months to establish chronic infection 2, 1, 2
- Anti-HBc total (IgG): This confirms chronic rather than acute infection and is universally positive in chronic hepatitis B 3, 4, 5
- HBV DNA: Detectable viral DNA confirms ongoing viral replication, with levels varying by disease phase 1, 5
Phase-Dependent Positive Markers
HBeAg-Positive Chronic Hepatitis B
- HBeAg positive: Indicates active viral replication and high infectivity 2, 1, 3
- Anti-HBe negative: Absence of this antibody confirms the active replication phase 3
- HBV DNA >20,000 IU/mL (or >105 copies/mL): Typically very high levels, often 200,000-2 billion IU/mL 1
- ALT/AST elevation: Persistent or intermittent elevation in most cases, though may be normal in immune tolerant phase 2, 1, 3
HBeAg-Negative Chronic Hepatitis B
- HBeAg negative: Loss of e antigen after seroconversion 1
- Anti-HBe positive: Presence of antibody to e antigen 1, 4
- HBV DNA >2,000 IU/mL: Lower than HBeAg-positive disease (typically 2,000-20 million IU/mL) but still elevated 1
- ALT/AST elevation: Fluctuating pattern is characteristic 1
Inactive HBsAg Carrier State (Still Chronic Infection)
- HBeAg negative 1, 4
- Anti-HBe positive 1, 4
- HBV DNA <2,000 IU/mL: Minimal viral replication 1, 4
- Normal ALT/AST: Persistently normal, distinguishing from active disease 1, 4
Additional Laboratory Findings
- Complete blood count: May show thrombocytopenia if advanced disease with portal hypertension 6
- Liver function tests: Albumin and prothrombin time/INR reflect synthetic function; may be normal in early disease or abnormal in advanced disease 7, 6, 8
- Bilirubin: Usually normal unless decompensation or acute flare 6
- Alkaline phosphatase/GGT: Typically normal or mildly elevated; marked elevation suggests cholestatic component 6
- AFP (alpha-fetoprotein): Baseline measurement for HCC surveillance, not diagnostic of chronic hepatitis B itself 7
Critical Markers That Are Negative
- Anti-HBs (antibody to surface antigen): Negative in chronic infection; positivity indicates immunity or resolved infection 4, 9
- IgM anti-HBc: Negative or low-titer; high levels indicate acute infection 3, 9
Important Clinical Caveats
Serial testing is mandatory because chronic hepatitis B is a dynamic disease with fluctuating markers. A single set of labs cannot definitively classify disease phase. 1, 4
Normal ALT does not exclude significant disease. Patients in the immune tolerant phase may have high HBV DNA (>20,000 IU/mL) with normal transaminases but still progress to cirrhosis and HCC. 2, 3, 6
10-30% of inactive carriers reactivate with elevated ALT and high HBV DNA after years of quiescence, requiring lifelong monitoring every 6-12 months. 1, 4
HBV DNA quantification is essential for proper classification and cannot be omitted. The diagnosis of inactive carrier state versus chronic hepatitis B is impossible without measuring HBV DNA levels. 1, 4
Coinfection testing is critical. All patients should be tested for anti-HCV, anti-HDV (if from endemic areas or injection drug use history), and anti-HIV in at-risk populations, as these alter prognosis and management. 1, 7